NCT04785625 - Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty | Biotech Hunter

Enrollment

366

Participants

Timeline

Start Date

April 29, 2021

Primary Completion Date

October 27, 2021

Study Completion Date

October 27, 2021

Conditions

Pain, PostoperativeAbdominoplasty

Interventions

COMBINATION_PRODUCT

Bupivacaine Hydrochloride

INL-001 (bupivacaine hydrochloride) implant

COMBINATION_PRODUCT

Placebo collagen-matrix implant

Trial Locations (4)

Midwest Clinical Research, Dayton

HD Research, Bellaire

Endeavor Clinical Trials, San Antonio

Lotus Clinical Research, Pasadena